1.Fleroxacin for Treating Lower Respiratory Tract Infections in 50 Patients
Herald of Medicine 2001;(5):308-309
bjective: To evaluate the efficacy and safety of fleroxacin injection in treating the lower respiratory tract infections. Methods: 50 patients with lower respiratory tract infections were treated with fleroxacin injection administered via intravenous drip, with a dosage of 0.2-0.4 g once daily for a consecutive of 7 days. Results:Effectiveness rate and bacteria eradication rate of fleroxacin were 90% and 87%, respectively. The incidence of adverse effects for fleroxacin were 6%. Conclusion: Fleroxacin injection is an effective and safe antibiotics for treating the lower respiratory tract infections.
2.The Effect of Ondansetron in Prevention of Chemotherapy-induced Nausea and Vomitus in Lung Cancer Patients
Dongfa QIU ; Tiaoheng HUANG ; Zhaolian ZHANG
Herald of Medicine 2001;(3):180-181
Objective:To evaluate the effect of single-dose ondansetron in prevention of chemotherapy-induced nausea and vomitus in lung cancer patients.Methods:35 lung cancer patients receiving chemotherapy were observed with self-comparisonal design.A single dose of 8mg ondansetron and of 20mg metoclopramide were administered by intravenous injection and intramuscular in jection to the patients at different time and the outcome was observed.Results:The control rates of nausea and vomitus by ondansetron were 91.4% and 94.3%,and 65.7% and 74.3% by metoclopramide respectively(P<0.05).Conclusion:A single-dose of ondansetron can effectively prevent nausea and vomitus in lung cancer patients caused by chemotherapy.
3.Changes in the pathogen spectrum of hospitalized adults with community-acquired pneumonia in Fujian Province: A multicenter, retrospective study from 2012 to 2018.
Fan WU ; Jian WU ; Nengluan XU ; Qunying LIN ; Dongfa QIU ; Xuhua LYU ; Ming LIN ; Wenxiang YUE ; Yan XIAO ; Lili REN ; Yusheng CHEN ; Hongru LI
Chinese Medical Journal 2023;136(8):989-991